Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-054562
Filing Date
2018-10-19
Accepted
2018-10-19 16:31:13
Documents
2
Period of Report
2018-10-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv505081_form3.html 3  
1 OWNERSHIP DOCUMENT tv505081_form3.xml 3 3470
2 EXHIBIT 24 tv505081_ex24.htm EX-24 10283
  Complete submission text file 0001144204-18-054562.txt   15398
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 33 5TH AVENUE NEW BRIGHTON MN 55112
Business Address
Wilson John Robert (Reporting) CIK: 0001755569 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37939 | Film No.: 181130744